Article tools
Author information

Research Article

Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.

N Shiga, Y Takeshima, H Sakamoto, K Inoue, Y Yokota, M Yokoyama and M Matsuo

Division of Genetics, International Center for Medical Research, Kobe University School of Medicine, Japan.

Published November 1, 1997

The mechanism of exon skipping induced by nonsense mutations has not been well elucidated. We now report results of in vitro splicing studies which disclosed that a particular example of exon skipping is due to disruption of a splicing enhancer sequence located within the exon. A nonsense mutation (E1211X) due to a G to T transversion at the 28th nucleotide of exon 27 (G3839T) was identified in the dystrophin gene of a Japanese Becker muscular dystrophy case. Partial skipping of the exon resulted in the production of truncated dystrophin mRNA, although the consensus sequences for splicing at both ends of exon 27 were unaltered. To determine how E1211X induced exon 27 skipping, the splicing enhancer activity of purine-rich region within exon 27 was examined in an in vitro splicing system using chimeric doublesex gene pre-mRNA. The mutant sequence containing G3839T abolished splicing enhancer activity of the wild-type purine-rich sequence for the upstream intron in this chimeric pre-mRNA. An artificial polypurine oligonucleotide mimicking the purine-rich sequence of exon 27 also showed enhancer activity that was suppressed by the introduction of a T nucleotide. Furthermore, the splicing enhancer activity was more markedly inhibited when a nonsense codon was created by the inserted T residue. This is the first evidence that partial skipping of an exon harboring a nonsense mutation is due to disruption of a splicing enhancer sequence.

Articles that cite
this article:

Synonymous SNPs Provide Evidence for Selective Constraint on Human Exonic Splicing Enhancers
David B. Carlini, Jordan E. Genut
J Mol Evol 62(1):89. [CrossRef]

Chimeric RNA/Ethylene-Bridged Nucleic Acids Promote Dystrophin Expression in Myocytes of Duchenne Muscular Dystrophy by Inducing Skipping of the Nonsense Mutation-Encoding Exon
Agus Surono, Tran Van khanh, Yasuhiro Takeshima, Hiroko Wada, Mariko Yagi, Miho Takagi, Makoto Koizumi, Masafumi Matsuo
Hum Gene Ther 15(8):749. [CrossRef]

DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients
Robert M.W. Hofstra, Inge M. Mulder, Rolf Vossen, Pia A. M. De koning-gans, Marian Kraak, Ieke B. Ginjaar, Annemarie H. Van der hout, Egbert Bakker, Charles H.C.M. Buys, Gert-Jan B. Van ommen
Hum Mutat 23(1):57. [CrossRef]

Nonsense-associated altered splicing of the Patched gene fails to suppress carcinogenesis in Gorlin syndrome
M. Laimer, K. Önder, P. Schlager, C.M. Lanschuetzer, M. Emberger, S. Selhofer, H. Hintner, J.W. Bauer
Br J Dermatol 159(1):222. [CrossRef]

Mutation spectrum leading to an attenuated phenotype in dystrophinopathies
Sylvie Tuffery-giraud, Céline Saquet, Delphine Thorel, Antoine Disset, François Rivier, Sue Malcolm, Mireille Claustres
Eur J Hum Genet 13(12):1254. [CrossRef]

Hematopoietic Cell Transplantation Provides an Immune-tolerant Platform for Myoblast Transplantation in Dystrophic Dogs
Maura H Parker, Christian Kuhr, Stephen J Tapscott, Rainer Storb
Mol Ther 16(7):1340. [CrossRef]

Automated splicing mutation analysis by information theory
Vijay K. Nalla, Peter K. Rogan
Hum Mutat 25(4):334. [CrossRef]

Three novel mutations (G27E, insAAC, R179X) in theORNT1 gene of Japanese patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome
Seiichi Tsujino, Naomi Kanazawa, Tohya Ohashi, Yoshikatsu Eto, Toyokazu Saito, Jun-Ichi Kira, Takeshi Yamada
Ann Neurol 47(5):625. [CrossRef]

Dystrophin expression in themdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide
Susan Fletcher, Kaite Honeyman, Abbie M. Fall, Penny L. Harding, Russell D. Johnsen, Steve D. Wilton
J Gene Med 8(2):207. [CrossRef]

Natural repair mechanisms in correcting pathogenic mutations in inherited skin disorders
M. F. Jonkman, M. Castellanos Nuijts, A. J. Van essen
Clin Exp Dermatol 28(6):625. [CrossRef]

Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1
Andrea Zatkova, Ludwine Messiaen, Ina Vandenbroucke, Rotraud Wieser, Christa Fonatsch, Adrian R. Krainer, Katharina Wimmer
Hum Mutat 24(6):491. [CrossRef]

Comparative Mutation Detection Screening of the Type VII Collagen Gene (COL7A1) Using the Protein Truncation Test, Fluorescent Chemical Cleavage of Mismatch, and Conformation Sensitive Gel Electrophoresis
Neil V. Whittock, Gabrielle H. S. Ashton, Rafik Mohammedi, Jemima E. Mellerio, Christopher G. Mathew, Stephen J. Abbs, Robin A. J. Eady, John A. Mcgrath
J Invest Dermatol 113(4):673. [CrossRef]

Dystrophin Nonsense Mutations Can Generate Alternative Rescue Transcripts in Lymphocytes
A. Nishiyama, Y. Takeshima, Z. Zhang, Y. Habara, T. H. T. Tran, M. Yagi, M. Matsuo
Ann Hum Genet 72(6):717. [CrossRef]

A nonsense mutation in exon 8 of the APC gene (Arg283Ter) causes clinically variable FAP in a Malaysian Chinese family
Zulqarnain Mohamed, Rahimah Ahmad, Ng Sau Yoke, Zubaidah Zakaria, Harun Ahmad, Tong Hung Yew
Cancer Sci 94(8):725. [CrossRef]

Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression
Zhi-Ming Zheng
J Biomed Sci 11(3):278. [CrossRef]

A nonsense mutation-created intraexonic splice site is active in the lymphocytes, but not in the skeletal muscle of a DMD patient
Van Khanh Tran, Yasuhiro Takeshima, Zhujun Zhang, Yasuaki Habara, Kazuhiro Haginoya, Atsushi Nishiyama, Mariko Yagi, Masafumi Matsuo
Hum Genet 120(5):737. [CrossRef]

Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons
Zhujun Zhang, Yasuaki Habara, Atsushi Nishiyama, Yoshinobu Oyazato, Mariko Yagi, Yasuhiro Takeshima, Masafumi Matsuo
J Hum Genet 52(7):607. [CrossRef]

Missense and nonsense mutations in the alternatively-spliced exon 2 of COL2A1 cause the ocular variant of Stickler syndrome
Audrey Mcalinden, Marja Majava, Paul N. Bishop, Rahat Perveen, Graeme CM. Black, Mary Ella Pierpont, Leena Ala-kokko, Minna Männikkö
Hum Mutat 29(1):83. [CrossRef]

A stop codon mutation in COL11A2 induces exon skipping and leads to non-ocular Stickler syndrome
Mirka Marjanna Vuoristo, John Georgios Pappas, Valerie Jansen, Leena Ala-kokko
Am J Med Genet 130a(2):160. [CrossRef]